Karlyne Reilly, PhD

Karlyne Reilly, PhD

Dr. Reilly is the Director of the Center for Cancer Research Rare Tumor Initiative in the National Cancer Institute and is co-leading MyPART (My Pediatric and Adult Rare Tumor network), a patient engagement network and collaborative research project to study rare solid tumors. Her research focuses on malignancies associated with Neurofibromatosis type 1, using model systems to better understand cancer drivers and genetic modifiers of cancer development. She received her Ph.D. in molecular and cellular biology from Harvard University and completed post-doctoral fellowship training at the Center for Cancer Research of MIT, where she held fellowships from the Leukemia & Lymphoma Society, the AACR-Sidney Kimmel Foundation, and the American Cancer Society. She has led a basic research group at the Center for Cancer Research since 2002.